As of 2024-11-03, the Fair Value of Vanda Pharmaceuticals Inc (VNDA) is -4.69 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.66 USD, the upside of Vanda Pharmaceuticals Inc is -200.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
Historical Earnings | ||||||
2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
Net income | 115.60 | 23.30 | 33.20 | 6.30 | 2.51 | 36.18 |
YoY growth | 358.73% | -79.84% | 42.49% | -81.02% | -60.17% | 36.04% |
Market Cap (mil) | 271.63 |
P/E | |
Forward P/E | 48.73x |
EPS | -0.19 |
Avg earnings growth rate | 36.04% |
TTM earnings | -10.92 |